Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$250.05 - $459.77
Next Earnings Date
Jul 21 2025 (Estimate)
Next Earnings Date
Jul 21 2025 (Est.)
Latest price
Market Cap | $8.35B |
EV | $8.06B |
Shares Outstanding | 29.05M |
Beta | 1.46 |
Analyst Rating | HOLD |
Analyst Target Price | $305.94 |
P/E 2025E | 22.89x |
P/Revenue 2025E | 3.83x |
Revenue | 22.70% |
EPS | 38.00% |
Operating Cash Flow | 32.20% |
Free Cash Flow | 34.50% |
Revenue | 5.20% |
EPS | 4.80% |
Operating Cash Flow | -3.30% |
Free Cash Flow | -3.60% |
Gross Margin 2025E | 30.97% |
Net Profit Margin 2025E | 17.80% |
ROE 2025E | 46.44% |
ROCE 2024 | 58.41% |
DPS 2025E | $0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Medpace Holdings, Inc.
MEDP
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Troendle, August
Employees
5,900
Website
www.medpace.comIPO Date
2016-08-11
Headquarters
5375 Medpace Way, Cincinnati, Ohio, 45227, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved